ProHealth fibromyalgia Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

The Cannabis Science Fibromyalgia Pain Patch: Fact or Fiction?

Brain Fog

Could Fibromyalgia Be A Low-Endorphin Disease?

Top 10 Benefits of Laughter for Fibromyalgia

Increased risk of a suicide event in patients with primary fibromyalgia and in fibromyalgia patients...

Beginning Again: Living with the Ups and Downs of Life with Chronic Illness

The Difference Between Fibromyalgia Tender Points and Myofascial Trigger Points

Chronic Christmas: Surviving the Holidays with a Chronic Illness

Are persons with fibromyalgia or other musculoskeletal pain more likely to report hearing loss? A HU...

Medical cannabis - the Canadian perspective.

 
Print Page
Email Article

Hunger Striker Decries FDA Denial of Ampligen & Seeks Help of Secretary Sebelius

  [ 9 votes ]   [ Discuss This Article ]
www.ProHealth.com • February 5, 2013


Hunger Striker Decries FDA Denial of Only Medicine for Chronic Fatigue Syndrome,
Asks Secretary Sebelius to start NIH Clinical Trial of Ampligen

News Release: February 4, 2013 (Updated February 5, 2013)

In day 7 of his hunger strike, Chronic Fatigue Syndrome patient Robert Miller decried FDA’s decision to disapprove Ampligen, the only medication in clinical trial for him and a million ill Americans. Mr. Miller is asking Secretary of Health Kathleen Sebelius to conduct clinical trials of Ampligen at the National Institutes of Health.

Because there is NO FDA-approved medication for CFS, and none in the pipeline, FDA’s decision forecloses any potential of an approved medicine for patients for years to come. Given the serious, life-threatening nature of CFS, as acknowledged by FDA, this denial creates an obligation for the Department of Health and Human Services and NIH to fill the 25-year void in drug development.

Dr. Nancy Klimas, one of the nation’s top CFS clinicians, stated in a statement , “The data shows that a subgroup of CFS/ME patients showed marked improvement, even recovery on the drug.” Until last year, Dr. Klimas was a member of the Secretary of Health's Chronic Fatigue Syndrome Advisory Committee.

Miller has been on Ampligen since 1999, and moved his family twice in 14 years to access the clinical trial. “Now the 100 or so patients on Ampligen like me risk losing the only treatment that clearly works for us. Ampligen transforms me from bedridden to being able to care for my twin boys.”

NIH promotes its ability to conduct clinical trials, and it has proudly launched the National Center for Translational Science to “bridge basic science and human medicine” and accelerate the process for developing therapeutics. “It is the perfect place to pursue larger clinical trials of Ampligen to understand how to identify responders and learn from the mechanism of the drug on patient’s immune systems. Imagine what we could learn,” said Miller.

Cleve Jones, founder of the AIDS Quilt, noted:   “CFS patients suffer without any treatments, and I can remember those days in my life. I urge Secretary Sebelius to apply what we learned with HIV about getting treatments to untreated patients like every minute counts.”

Anita Patton, a CFS patient who has been on and off Ampligen at different times over 15 years, was outraged. Last year, Patton was in a wheelchair, unable to prepare her own meals. “After a year of Ampligen, I have my life back. I was there at the December hearing, where the FDA staff listened to my story and turned to the Advisory Panel and said Ampligen doesn’t work.”

Thousands petitioned FDA for Ampligen’s approval.

Last fall, President Obama urged Secretary Sebelius to “elevate CFS in priority at HHS,” following a promise he made to my wife Courtney at a Reno Town Hall meeting. The first act of the President’s second administration on CFS is to reject this only medicine.

CFS affects 1 million Americans, costs our government $20 billion annually, and disables approximately 25% of patients, according to peer-reviewed research. FDA’s objections center on the lack of clear biomarkers to measure effectiveness of Ampligen. The absence of those biomarkers is the result of negligible research by the NIH into abnormalities of the disease, amounting to a measly $6 million per year.

Patient videos online at Facebook page Hunger Strike for Ampligen Approval for CFS.

Read the original Reno NBC story.  Read the January 5, 2013 Reno NBC update .




Post a Comment

Featured Products From the ProHealth Store
B-12 Extreme™ Guaifenesin FA™ Hydroxocobalamin Extreme™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Hydroxocobalamin Extreme™ Hydroxocobalamin Extreme™
The B-12 Your Brain Needs for Detox & Sharpness
Guaifenesin FA™ Guaifenesin FA™
Helps the Body Eliminate Excess Calcium and Phosphates
Fibro Freedom™ Fibro Freedom™
Soothes, Strengthens & Revitalizes

Natural Remedies

Secret Nutrient for Radiant Skin Secret Nutrient for Radiant Skin
Are You Obtaining the Proper Enzymes? Are You Obtaining the Proper Enzymes?
Breaking Through the Mental Fog Breaking Through the Mental Fog
D-ficient? Health Risks You Need to Know About D-ficient? Health Risks You Need to Know About
The Remarkable Benefits of Reishi Medicinal Mushrooms The Remarkable Benefits of Reishi Medicinal Mushrooms

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map